Orphan drug designation granted to Octreolin for oral treatment of acromegaly - MPR
Links shared publicly online about this topic.
- 1,060total visits
Orphan drug designation granted to Octreolin for oral treatment of acromegaly - MPR
empr.com —
View full resource at empr.com
Tags: Hormone, Acromegaly, Disease and Condition, Drug, FDA, News
Most Recently Shared on June 28, 2010 at 9:23 pm By:
MPR News: Orphan drug designation granted to Octreolin for oral treatment of acromegaly: Chiasma, Inc. was granted... http://bit.ly/96Qd2i
Chiasma Receives Orphan Drug Designation From The FDA For Octreolin™ For The Oral Treatment Of Acromegaly
medicalnewstoday.com — “Chiasma, Inc., a privately held biopharma company, announced that the Food and Drug Administration (FDA) has granted orphan drug designation for Chiasma's investigational new drug, Octreolin, an o” View full resource at medicalnewstoday.com
Most Recently Shared on June 29, 2010 at 1:07 pm By:
Chiasma Receives Orphan Drug Designation From The FDA For Octreolin™ For The Oral Treatment Of Acromegaly http://mnt.to/3FtJ
Chiasma Receives Orphan Drug Designation From the FDA for Octreolin" for... -- NEW YORK and JERUSALEM, June 28 /PRNewswire/ --
prnewswire.com — “Chiasma Receives Orphan Drug Designation From the FDA for Octreolin" for the Oral Treatment of Acromegaly.” View full resource at prnewswire.com
Most Recently Shared on June 28, 2010 at 1:18 pm By:
eyeonfda Pharma and Health Lawyer
Chiasma Receives Orphan Drug Designation From the FDA for Octreolinâ„¢ for the Oral Treatment of Acromegaly - http://ow.ly/247Nu
Advertisement
